Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Longeveron

LGVN

7.33010.39% ( +0.690 )

Closed: Sep 11, 16:00:01 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Longeveron (LGVN)

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its...

Open: 6.790
High: 7.360
Low: 6.640
Prev. Close: 6.640
Volume: 68.15K
Turnover: 483.93K
Avg Price: 7.101
Bid/Ask Ratio: --
Amplitude: 10.84%
52wk High: 12.300
Volume Ratio: 0.50
Turnover Ratio: 2.65%

52wk Low: 4.750
Float Mkt Cap: 18.83M
Market Cap^USD: 23.37M
P/E^TTM: Loss
P/E^Dynamic: Loss
P/E^Static: --
EPS^TTM: -7.36
EPS^Dynamic: -6.78
EPS^Static: --
BVPS: 3.26
P/B: 2.25
Circulating Supply: 2.57M
Dividend Yield^TTM: --
Dividend^TTM: --
Shares: 3.19M
Min lot size: 1
Currency: USD

Longeveron Analyst Rating

Forecast & Rating

Aug 19, 2026

Price forecast

$71.50875.44%

Forecast & RatingBuy

3analysts

Strong buy66.67%
Buy0.00%
Hold33.33%
Sell0.00%
Strong sell0.00%

Strong buy: 2
Buy: 0
Hold: 1
Sell: 0
Strong sell: 0

News

PUBT · Sep 3 at 01:15 PM
Longeveron to present at H.C. Wainwright Global Investment Conference
PUBT · Aug 26 at 10:51 AM
Longeveron CFO Nirav S. Jhaveri files initial beneficial ownership statement
benzinga_article · Aug 25 at 08:02 AM
Dick's Sporting Goods, Intuit And 3 Stocks To Watch Heading Into Tuesday
benzinga_article · Aug 24 at 09:06 PM
12 Health Care Stocks Moving In Monday's After-Market Session